Passa al contenuto
Merck

Documenti fondamentali

Visualizza tutta la documentazione

Vai a

05316

Atto 647N maleimide

BioReagent, suitable for fluorescence, ≥90% (HPLC)

Autenticati per visualizzare i prezzi organizzativi e contrattuali.

Scegli un formato

Cambia visualizzazione
Taglio della confezioneSKUDisponibilitàPrezzo
1 mg
Per conoscere la disponibilità, visualizza il carrello
CHF 517.00

Informazioni su questo articolo

UNSPSC Code:
12352111
NACRES:
NA.32
MDL number:
MFCD07370581
Manufacturer/tradename:
ATTO-TEC GmbH

CHF 517.00

Per conoscere la disponibilità, visualizza il carrello
​
Richiedi un ordine in blocco
Servizio Tecnico
Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.
Permettici di aiutarti

product line

BioReagent

Quality Segment

100

assay

≥90% (HPLC), ≥90% (degree of coupling)

manufacturer/tradename

ATTO-TEC GmbH

λ

in ethanol (with 0.1% trifluoroacetic acid)

UV absorption

λ: 640-646 nm Amax

suitability

suitable for fluorescence

detection method

fluorometric

storage temp.

−20°C

Application


  • Preparation of homogeneous samples of double-labelled protein suitable for single-molecule FRET measurements.: This study explores the use of Atto 647N maleimide for the preparation of homogeneously double-labelled protein samples, facilitating precise single-molecule FRET measurements to analyze protein dynamics and interactions (Lerner et al., 2013).

Legal Information

This product is for Research use only. In case of intended commercialization, please contact the IP-holder (ATTO-TEC GmbH, Germany) for licensing.

Confronta articoli simili

Visualizza il confronto per intero

Mostra le differenze

1 of 1

Questo articolo
045070871765906
Atto 647N maleimide BioReagent, suitable for fluorescence, ≥90% (HPLC)

Supelco

05316

Atto 647N maleimide

Atto 647N BioReagent, suitable for fluorescence, ≥90.0% (HPLC)

Supelco

04507

Atto 647N

Atto 594 maleimide BioReagent, suitable for fluorescence, ≥90% (Coupling efficiency with N-Acetylcysteine, HPLC)

Supelco

08717

Atto 594 maleimide

Phalloidin–Atto 647N BioReagent, suitable for fluorescence, ≥80% (HPLC)

Sigma-Aldrich

65906

Phalloidin–Atto 647N

manufacturer/tradename

ATTO-TEC GmbH

manufacturer/tradename

ATTO-TEC GmbH

manufacturer/tradename

ATTO-TEC GmbH

manufacturer/tradename

ATTO-TEC GmbH

UV absorption

λ: 640-646 nm Amax

UV absorption

λ: 640.0-646.0 nm Amax

UV absorption

-

UV absorption

λ: 640-646 nm Amax

Quality Level

100

Quality Level

100

Quality Level

100

Quality Level

100

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

suitability

suitable for fluorescence

suitability

suitable for fluorescence

suitability

suitable for fluorescence

suitability

suitable for fluorescence

assay

≥90% (HPLC), ≥90% (degree of coupling)

assay

≥90.0% (HPLC)

assay

≥90% (Coupling efficiency with N-Acetylcysteine, HPLC)

assay

≥80% (HPLC)

Classe di stoccaggio

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number
BCCP6222
BCCP4890
BCCP3194
BCCP0730
BCCN9630

Non trovi la versione di tuo interesse?

Se hai bisogno di una versione specifica, puoi cercare il certificato tramite il numero di lotto.

Cerca un COA

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

S E D Webb et al.
Optics express, 16(25), 20258-20265 (2008-12-10)
We combine single molecule fluorescence orientation imaging with single-pair fluorescence resonance energy transfer microscopy, using a total internal reflection microscope. We show how angles and FRET efficiencies can be determined for membrane proteins at the single molecule level and provide
Marina I Giannotti et al.
Biomacromolecules, 12(7), 2524-2533 (2011-05-25)
Nanopharmaceutics composed of a carrier and a protein have the potential to improve the activity of therapeutical proteins. Therapy for lysosomal diseases is limited by the lack of effective protein delivery systems that allow the controlled release of specific proteins
STED microscopy to monitor agglomeration of silica particles inside A549 cells.
Schubbe, S., et al.
Advanced Engineering Materials, 12, 417-422 (2010)
Visualizza tutti i documenti correlati

Numero articolo commerciale globale

SKUGTIN
160474-25G04061838346353
160474-5G04061838745590
05316-1MG-F04061838637321

Questions

Reviews

No rating value

Active Filters